Volume 17, Issue 10, Pages (October 2018)

Slides:



Advertisements
Similar presentations
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Large, Nonplateauing Relationship Between Clinical.
Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease  C Bjartmar, J.R Wujek, B.D Trapp  Journal of.
Relationship between Diffusion Tensor Fractional Anisotropy and Motor Outcome in Patients with Hemiparesis after Corona Radiata Infarct  Tetsuo Koyama,
Volume 362, Issue 9397, Pages (November 2003)
MRI findings in MS. A. Axial first-echo image from T2-weighted sequence demonstrates multiple bright signal abnormalities in white matter, typical for.
Okadaic-Acid-Induced Inhibition of Protein Phosphatase 2A Produces Activation of Mitogen-Activated Protein Kinases ERK1/2, MEK1/2, and p70 S6, Similar.
Volume 86, Issue 5, Pages (June 2015)
Johanna Sigl-Glöckner, Michael Brecht  Cell Reports 
Nat. Rev. Neurol. doi: /nrneurol
Reversible cerebral vasoconstriction syndrome
Volume 17, Issue 6, Pages (June 2010)
Volume 78, Pages (January 2018)
Stephen L. Hauser, Jorge R. Oksenberg  Neuron 
Genetic Malformations of the Human Cerebral Cortex
Vincentius J. A. Verlinden, MSc, Jos N
Volume 80, Issue 2, Pages (October 2013)
Volume 71, Issue 5, Pages (September 2011)
Araceli Ramirez-Cardenas, Maria Moskaleva, Andreas Nieder 
Neuropathological and MRI findings in an acute presentation of hemiconvulsion- hemiplegia: A report with pathophysiological implications  Stéphane Auvin,
Dyspnea-Related Cues Engage the Prefrontal Cortex
Figure 1 Coronal MRI images showing the evolution of white matter abnormality and atrophy of patient 1 Coronal MRI images showing the evolution of white.
Volume 77, Issue 5, Pages (March 2013)
Cerebral Outcome in Adult Patients Treated With Extracorporeal Membrane Oxygenation  Ivar Risnes, MD, PhD, Kari Wagner, MD, Terje Nome, MD, Kjetil Sundet,
Cognitive Neurology: Stimulating Research on Neglect
Volume 49, Issue 1, Pages (January 2013)
Deep Brain Stimulation for Treatment-Resistant Depression
Michael Ewers, Reisa A. Sperling, William E. Klunk, Michael W
Volume 9, Issue 1, Pages (January 2010)
Volume 85, Issue 1, Pages (January 2015)
Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms
Volume 77, Issue 2, Pages (January 2013)
Insights into Human Behavior from Lesions to the Prefrontal Cortex
Kevin R. Duffy, Donald E. Mitchell  Current Biology 
Volume 15, Issue 12, Pages (June 2005)
Volume 12, Issue 9, Pages (September 2013)
Low-level lead exposure and mortality in US adults: a population-based cohort study  Prof Bruce P Lanphear, MD, Stephen Rauch, MPH, Peggy Auinger, MS,
Volume 74, Issue 4, Pages (May 2012)
Volume 53, Issue 1, Pages 3-12 (July 2015)
Talia Konkle, Aude Oliva  Neuron  Volume 74, Issue 6, Pages (June 2012)
Integration of Touch and Sound in Auditory Cortex
James G. Heys, Krsna V. Rangarajan, Daniel A. Dombeck  Neuron 
Jonathan J. Nassi, David C. Lyon, Edward M. Callaway  Neuron 
Volume 45, Issue 4, Pages (February 2005)
Kevin R. Duffy, Donald E. Mitchell  Current Biology 
Volume 10, Issue 8, Pages (March 2015)
Johanna Sigl-Glöckner, Michael Brecht  Cell Reports 
Transient and Persistent Dendritic Spines in the Neocortex In Vivo
Volume 74, Issue 1, Pages (April 2012)
Volume 19, Issue 1, Pages (July 1997)
Rosanna P. Sammons, Claudia Clopath, Samuel J. Barnes  Cell Reports 
Neuropathology of epilepsy: epilepsy-related deaths and SUDEP
Diseases Involving Myelin
Figure MRI and neuropathologic characteristics of the tumefactive demyelinating lesion in our patient MRI and neuropathologic characteristics of the tumefactive.
Action Selection and Action Value in Frontal-Striatal Circuits
Volume 22, Issue 18, Pages (September 2012)
Michael S. Beauchamp, Kathryn E. Lee, James V. Haxby, Alex Martin 
Volume 74, Issue 2, Pages (April 2012)
Volume 10, Issue 8, Pages (March 2015)
Neural Primacy of the Salience Processing System in Schizophrenia
Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice  Mohammad A.
Ashkan Javaherian, Hollis T. Cline  Neuron 
Michael S. Beauchamp, Kathryn E. Lee, James V. Haxby, Alex Martin 
R.A. Armstrong, P.L. Lantos, N.J. Cairns  Pathophysiology 
Volume 16, Issue 2, Pages (July 2016)
Perceptual Classification in a Rapidly Changing Environment
Volume 11, Issue 3, Pages (April 2015)
Christian J. Fiebach, Jesse Rissman, Mark D'Esposito  Neuron 
Volume 74, Issue 5, Pages (June 2012)
Clark Fisher, Winrich A. Freiwald  Current Biology 
Presentation transcript:

Volume 17, Issue 10, Pages 870-884 (October 2018) Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study  Prof Bruce D Trapp, PhD, Megan Vignos, PhD, Jessica Dudman, BS, Ansi Chang, MD, Elizabeth Fisher, PhD, Susan M Staugaitis, PhD, Harsha Battapady, MD, Prof Sverre Mork, MD, Daniel Ontaneda, MD, Prof Stephen E Jones, MD, Prof Robert J Fox, MD, Jacqueline Chen, PhD, Kunio Nakamura, PhD, Prof Richard A Rudick, MD  The Lancet Neurology  Volume 17, Issue 10, Pages 870-884 (October 2018) DOI: 10.1016/S1474-4422(18)30245-X Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure 1 Demyelination in myelocortical multiple sclerosis and typical multiple sclerosis (A) A centimetre-thick slice from a typical multiple sclerosis brain that contains a large white-matter lesion (arrow). (B) A centimetre-thick slice from a myelocortical multiple sclerosis brain without white-matter lesions. (C) A normally myelinated spinal cord section labelled with antiPLP antibodies. (D and E) Spinal cord demyelination was detected in tissue sections from individuals with typical multiple sclerosis (D) and myelocortical multiple sclerosis (E). (F) Normally myelinated cortex labelled with an antiPLP antibody. (G and H) Subpial cortical lesions in typical multiple sclerosis (G) and myelocortical multiple sclerosis (H). Black lines separate spinal cord grey and white matter (C–E) and cortical and subcortical white matter (F–H). PLP=myelin proteolipid protein. The Lancet Neurology 2018 17, 870-884DOI: (10.1016/S1474-4422(18)30245-X) Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure 2 Neuronal loss in the absence of cerebral white-matter demyelination (A) A cresyl violet-stained coronal hemispheric section from an individual classed as having typical multiple sclerosis. Neuronal densities were compared in cortical layers III, V, and VI in each of the five labelled areas. (B) Neurons with an area greater than 60 μm2 (yellow) are shown in a representive image from the superior temporal cortex. (C and D) Labelling for myelin proteolipid protein and the distribution of demyelinated lesions (white-matter demyelination is highlighted in blue; subpial demyelination is highlighted in pink) in hemispheric sections from individuals with typical multiple sclerosis (C) and myelocortical multiple sclerosis (D). (E) A significant correlation between reduced cortical neuronal density and increased cerebral white-matter lesion volume was found in typical multiple sclerosis, but not in myelocortical multiple sclerosis; dashed lines indicate 95% CI. IFG=inferior frontal gyrus. STG=superior temporal gyrus. INi=inferior insula. INs=superior insula. CG=cingulate gyrus. MS=multiple sclerosis. The Lancet Neurology 2018 17, 870-884DOI: (10.1016/S1474-4422(18)30245-X) Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure 3 MRI in myelocortical multiple sclerosis and typical multiple sclerosis Representative T2-weighted, fluid-attenuated inversion recovery images post-mortem from brains of individuals with typical multiple sclerosis (A) and myelocortical multiple sclerosis (B). The Lancet Neurology 2018 17, 870-884DOI: (10.1016/S1474-4422(18)30245-X) Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure 4 Pathological correlates of cerebral white-matter imaging abnormalities in myelocortical multiple sclerosis A brain slice from an individual with myelocortical multiple sclerosis (A) is co-registered with T1-weighted (B), T2-weighted (C), and MTR (D) images. The red circle indicates a normal-appearing white-matter region, as defined by no imaging abnormalities. The blue circle indicates a region of interest that is abnormal in T2-weighted, T1-weighted, and MTR images (T2-T1-MTR). (E and F) Axonal staining in tissue sections of the normal-appearing white-matter (E) and T2-T1-MTR (F) regions. (A–D) Scale bars show 20 μm. (G) Measurements of myelin area, axonal area, axonal numbers, and axonal diameter in 46 normal-appearing white-matter regions and 31 T2-T1-MTR regions. Data in error bars are mean and SD of fraction of normal-appearing white-matter, n=10, p=0·82. (H and I) Average axonal diameter versus normalised T1-weighted intensity (H) and MTR (I) derived from linear models where group, age, and sex were specified as fixed factors, and patient was specified as a random factor; individual dot colours represent ten individual patients, and dashed lines indicate 95% CI. NAWM=normal appearing white-matter region. MTR=magnetisation transfer ratio. The Lancet Neurology 2018 17, 870-884DOI: (10.1016/S1474-4422(18)30245-X) Copyright © 2018 Elsevier Ltd Terms and Conditions